Patients' attitudes towards generic drug substitution in Japan

Health Policy

Volumn 99, Issue 1, 2011, Pages 60-65

  Kobayashi, Eriko ^a   Karigome, Hiroshi ^a   Sakurada, Tomoya ^a   Satoh, Nobunori ^a   Ueda, Shiro ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Generic drug substitution; Japan; Patients' attitudes

Indexed keywords

GENERIC DRUG;

ADULT; ARTICLE; DRUG SUBSTITUTION; FEMALE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PHARMACIST; PHYSICIAN; PRESCRIPTION; STRUCTURED QUESTIONNAIRE;

ADULT; ATTITUDE; DRUGS, GENERIC; FEMALE; HEALTH SURVEYS; HUMANS; JAPAN; MALE; MIDDLE AGED; PATIENTS; YOUNG ADULT;

EID: 78649932599     PISSN: 01688510     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healthpol.2010.07.006     Document Type: Article

References (25)

1. Ministry of Health, Labor and Welfare. Medical Insurance System in Japan. Retrieved 12 August 2009 from http://www.mhlw.go.jp/bunya/iryouhoken/iryouhoken01/01.html.
2. Ministry of Finance, Cost of pharmaceuticals. (Japanese). Retrieved 31 May 2010 from http://www.mof.go.jp/singikai/zaiseseido/siryou/zaiseib190516/02-2c.pdf.
3. Ministry of Health, Labour and Welfare, Pharmaceuticals on Reimbursement List. (Japanese). Retrieved 31 May 2010 from http://www.mhlw.go.jp/shingi/2008/12/dl/s1217-15e.pdf.
4. Ministry of Health, Labor and Welfare. Recent spending for prescription drugs in FY2008. Retrieved 30 June 2010 from http://www.mhlw.go.jp/topics/medias/year/08/gaiyou.html.
5. U.S. Food and Drug Administration. Generic Drugs: What Everyone Should Know. Retrieved 31 May 2010 from http://www.fda.gov/Drugs/EmergencyPreparedness/BioterrorismandDrugPreparedness/ucm134154.htm.
6. Shrank W.H., Cox E.R., Fischer M.A., Mehta J., Choudhry N.K. Patients' perceptions of generic medications. Health affairs (Millwood) 2009, 28(2):546-556.
7. Iosifescu A., Halm E.A., McGinn T., Siu A.L., Federman A.D. Beliefs about generic drugs among elderly adults in hospital-based primary care practices. Patient Education and Counseling 2008, 73(2):377-383.
8. Figueiras M.J., Marcelino D., Cortes M.A. People's views on the level of agreement of generic medicines for different illnesses. Pharmacy World & Science 2008, 30(5):590-594.
9. Vallès J.A., Barreiro M., Cereza G., Ferro J.J., Martínez M.J., Escribà J.M., Iglesias B., Cucurull E., Barceló E. A prospective multicenter study of the effect of patient education on acceptability of generic prescribing in general practice. Health Policy 2003, 65(3):269-275.
10. Himmel W., Simmenroth-Nayda A., Niebling W., Ledig T., Jansen R.D., Kochen M.M., Gleiter C.H., Hummers-Pradier E. What do primary care patients think about generic drugs?. International Journal of Clinical Pharmacology and Therapeutics 2005, 43(10):472-479.
11. Engström A, Jacob J, Lundin D. Sharp drop in prices after the introduction of genetic substitution. 31 May 2010 retrieved from http://ppri.oebig.at/Downloads/Sweden_EffectsGenericSubstitution.pdf.
12. Andersson K., Sonesson C., Petzold M., Carlsten A., Lönnroth K. What are the obstacles to generic substitution? An assessment of the behaviour of prescribers, patients and pharmacies during the first year of generic substitution in Sweden. Pharmacoepidemiology and Drug Safety 2005, 14(5):341-348.
13. Heikkilä R., Mäntyselkä P., Hartikainen-Herranen K., Ahonen R. Customers' and physicians' opinions of and experiences with generic substitution during the first year in Finland. Health Policy 2007, 82(3):366-374.
14. Kjoenniksen I., Lindbaek M., Granas A.G. Patients' attitudes towards and experiences of generic drug substitution in Norway. Pharmacy World & Science 2006, 28:284-289.
15. Kersnik J., Peklar J. Attitudes of Slovene general practitioners towards generic drug prescribing and comparison with international studies. Journal of Clinical Pharmacy and Therapeutics 2006, 31(6):577-583.
16. Harding G., Wilcock M. Community pharmacists' perceptions of medicines use reviews and quality assurance by peer review. Pharmacy World & Science 2010, 32(3):381-385.
17. Chong C.P., Hassali M.A., Bahari M.B., Shafie A.A. Evaluating community pharmacists' perceptions of future generic substitution policy implementation: a national survey from Malaysia. Health Policy 2010, 94(1):68-75.
18. Beecroft G. Generic drug policy in Australia: a community pharmacy perspective. Australian & New Zealand Health Policy 2007, 4:7.
19. Hassali M.A., Shafie A.A., Jamshed S., Ibrahim M.I., Awaisu A. Consumers' views on generic medicines: a review of the literature. International Journal of Pharmaceutics and Practice 2009, 17(2):79-88.
20. Håkonsen H., Eilertsen M., Borge H., Toverud E.L. Generic substitution: additional challenge for adherence in hypertensive patients?. Current Medical Research and Opinion 2009, 25(10):2515-2521.
21. Shrank W.H., Cadarette S.M., Cox E., Fischer M.A., Mehta J., Brookhart A.M., Avorn J., Choudhry N.K. Is there a relationship between patient beliefs or communication about generic drugs and medication utilization?. Medical Care 2009, 47(3):319-325.
22. Van Wijk B.L., Klungel O.H., Heerdink E.R., de Boer A. Generic substitution of antihypertensive drugs: does it affect adherence?. The Annals of Pharmacotherapy 2006, 40(1):15-20.
23. Ganther J.M., Kreling D.H. Consumer perceptions of risk and required cost savings for generic prescription drugs. Journal of the American Pharmaceutical Association (Wash) 2000, 40(3):378-383.
24. Ministry of Health, Labour and Welfare. Survey of Physicians, Dentists and Pharmacists: 2008 (Japanese). Retrieved 31 May 2010 from http://www.mhlw.go.jp/toukei/saikin/hw/ishi/08/index.html.
25. Ministry of Health, Labour and Welfare. Basic Statistics of Regional Public Health and Medical Care: 2009 (Japanese). Retrieved 31 May 2010 from http://www.mhlw.go.jp/toukei/saikin/hw/hoken/kiso/21.html.